Artificial Intelligence from ScreenPoint Medical and Volpara Health Demonstrates Ability to Predict Long-Term Breast Cancer Risk
(Adnkronos) – Research from Mayo Clinic and UCSF find that the combination of Transpara ® Exam Score with Volpara TruDensity® can predict long-term risk of invasive breast cancers NIJMEGEN, Netherlands and WELLINGTON,
